Niquitin Mint (Nicotine Resinate)

Nicotine resinate, the active ingredient in Niquitin Mint, is a nicotine replacement therapy presented as an oromucosal product for oral mucosa use. It delivers nicotine via the mucosal membranes to help adult smokers manage withdrawal symptoms, cravings, and dependence effectively during cessation attempts.

GNH USA supplies Niquitin Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals, clinics, and procurement teams worldwide, adhering to stringent quality standards and regulatory requirements across multiple markets. The product is manufactured under GMP conditions and undergoes comprehensive testing to ensure purity and consistency.

Niquitin Mint, containing nicotine resinate, is used within the nicotine replacement therapy pathway to aid smoking cessation.

- Smoking cessation: assists adult smokers in reducing withdrawal symptoms while quitting. - Tobacco dependence: provides controlled nicotine to support gradual reduction of tobacco use. - Nicotine addiction: alleviates cravings during cessation attempts.

Niquitin Mint may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation or soreness - Nausea or upset stomach - Headache - Dizziness

Serious or Rare Side Effects: - Allergic reaction such as rash, swelling, or anaphylaxis - Cardiovascular events including increased heart rate or hypertension - Severe mouth ulceration or tissue damage

Before using Niquitin Mint, consider the following precautions to ensure safe and effective use.

- Pregnancy: safety not established; consult a healthcare professional before use. - Breastfeeding: unknown safety; weigh potential benefits against risks. - Cardiovascular disease: use with caution as nicotine may affect heart rate and blood pressure. - Age restriction: not recommended for individuals under 18 years of age. - Store at below 25°C: keep in the original packaging, protect from moisture and heat.

Niquitin Mint can interact with certain medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): combined use may increase cardiovascular risk. - CYP2A6 inhibitors: may alter nicotine metabolism leading to higher systemic exposure. - Concurrent use of other nicotine replacement products: risk of nicotine overdose.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: nicotine may reduce their efficacy, requiring monitoring. - Antipsychotic medications: nicotine can affect plasma levels, necessitating dose adjustments. - Alcohol consumption: may enhance nicotine cravings and affect tolerability.